Guangdong Rongtai Pharmaceutical Co.,Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Guangdong Rongtai Pharmaceutical Co.,Ltd. - overview
Established
2004
Location
Guangzhou, Guangdong, China
Primary Industry
Healthcare
About
Established in 2004 and based in Guangzhou, China, Guangdong Rongtai Pharmaceutical Co. ,Ltd. is a service provider that focuses on comprehensive services of Internet marketing and supply chain management for pharmaceutical companies. In 2020, the company changed its name from Guangdong Kanghong Medicine Co.
,Ltd. to Guangdong Rongtai Pharmaceutical Co. ,Ltd.. The company engages in providing medical delivery services.
The drugs it provides include azelastine hydrochloride nasal spray, alogliptin benzoate tablets, entecavir tablets and indapamide sustained-release capsules, etc. The company markets products through e-commerce and new retail. The company engages in B2B and B2C.
Current Investors
Hollyhigh International Capital, Oriental Fortune Capital, Hidea Investment
Primary Industry
Healthcare
Sub Industries
eMarketing/Digital Marketing, Healthcare
Website
www.khpharm.com
Verticals
E-commerce
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.